Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin prophylaxis to prevent gestational diabetes in obese pregnant women
IRCT20200113046112N1Phase 3Completed
- Sponsor
- Urmia University of Medical Sciences
- Start
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of metformin in gestational diabetes mellitus (GDM) (2 arms), sponsored by Urmia University of Medical Sciences. Primary endpoints: Frequency of gestational diabetes mellitus, Required insulin dosage in gestational diabetes mellitus patients and 1 more. Started Jan 2020; status: completed.
02
Drugs
metformin
03
Conditions
gestational diabetes mellitus (GDM)
Beyond the preview
Go deeper on IRCT20200113046112N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200113046112N1.